We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




New Surgical Approach for Bladder Cancer

By HospiMedica staff writers
Posted on 07 May 2001
New findings on advanced bladder cancer treatment suggest that transurethral resection with adjuvant therapy produces the same results as removing the bladder. More...
The findings were presented at the annual Update in Urology conference in Tampa (FL, USA) by Ralph deVere White, chair of the urology department at the University of California Davis Medical Center (Davis, USA).

The standard treatment for advanced bladder cancer is a radical cystectomy to remove the bladder, the lymph nodes and surrounding cancerous tissue. The new step-by-step approach, which has been offered to patients at the UC Davis Center for many years, calls for transurethral resection surgery to remove the bladder tumor, followed by additional surgeries to monitor cancer cell growth. Subsequent steps would depend on whether tissue samples test negative or positive for additional cancer. Adjuvant therapy is suggested to further improve survival. Cystectomy would remain an alternative..

Investigators at other institutions have also found that both approaches produce the same result. Dr. White believes the sequential approach could reduce the need for bladder removal by as much as 50%. "Based on these figures, we can save about half of the patients with invasive bladder cancer from a cystectomy and give them the same 10-year survival,” he noted.



Related Links:
Univ of California Davis Medical Center

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.